Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS)
- 30 November 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 146 (5), 870-875
- https://doi.org/10.1016/s0002-8703(03)00412-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical managementJournal of the American College of Cardiology, 2000
- Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and FibrinolysisArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Effect of Hormone Replacement Therapy on the Validity of the Friedewald Equation in Postmenopausal Women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) TrialJournal of Clinical Epidemiology, 1999
- Effect of Statins on Risk of Coronary DiseaseJAMA, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Heart and Estrogen/progestin Replacement Study (HERS)Controlled Clinical Trials, 1998
- Cholesterol Reduction Yields Clinical BenefitCirculation, 1998
- Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the Laboratory Standardization Panel of the National Cholesterol Education Program.Clinical Chemistry, 1988
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976